According to the latest report by IMARC Group, the — global alopecia treatment market exhibited moderate growth during 2015-2020. Looking forward, the market expects to grow at a CAGR of around 5% during 2021-2026.
Alopecia is an autoimmune disorder affecting the hair follicles that prevents the growth of hair on the scalp, face and body. Often resulting in hair loss and even baldness, it is commonly caused as a result of unhealthy diets, age, lifestyle changes, hormonal imbalance and hypertension. Its treatment aims to stimulate hair growth by suppressing the immune system. Some of the widely used drugs for treating alopecia include corticosteroids, minoxidil and anthralin.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/alopecia-treatment-market/requestsample
The global market is primarily driven by significant growth in the healthcare industry. Along with this, continual technological advancements across the sector are contributing to the market growth. For instance, the increasing deployment of advanced technologies, such as low light laser therapy (LLLT) that is safer and less invasive, is creating a positive outlook for the market. Moreover, the rising preference for maintaining an aesthetic appearance among the masses due to the growing popularity of social media is acting as a major growth-inducing factor. Other factors, including the increasing healthcare expenditure and extensive research and development (R&D) activities, are also providing an impetus to the market growth.
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Aclaris Therapeutics, Inc. (ACRS), Cellmid Limited, Cipla Limited (CIPLA.NS), Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc (GSK), HCell Inc., Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Taisho Pharmaceutical Holdings Co. Ltd and Teva Pharmaceutical Industries Ltd.
For more information about this report visit: https://www.imarcgroup.com/alopecia-treatment-market
The report has segmented the market on the basis of Type, Drug Class, Route of Drug Administration, Distribution Channel and Region.
Market Breakup by Drug Type:
Market Breakup by Indication:
Market Breakup by Gender:
Market Breakup by Route of Administration:
Market Breakup by Distribution Channel:
Market Breakup by Region:
Middle East and Africa
Browse related reports:
Global Nanorobotics Market Report: https://www.imarcgroup.com/nanorobotics-market
Global Health Insurance Market: https://www.imarcgroup.com/health-insurance-market
Global Freeze-Drying Equipment Market : https://www.imarcgroup.com/freeze-drying-equipment-market
Global Portable Oxygen Concentrators Market Size: https://www.imarcgroup.com/portable-oxygen-concentrators-market
Global Carbon Dioxide Incubators Market Report: https://www.imarcgroup.com/carbon-dioxide-incubators-market
Global Alzheimer’s Drugs Market Report: https://www.imarcgroup.com/alzeimers-drugs-market
Global Blood Culture Test Market Report: https://www.imarcgroup.com/blood-culture-test-market
Body Contouring Market Report: https://www.imarcgroup.com/body-contouring-market
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, and nanotechnology industries. We also provide cost model and manufacturing setup project reports through Syndicated Analytics, a subsidiary of IMARC Group.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Name: Elena Anderson
Email: Send Email
Organization: IMARC Group
Address: 30 N Gould St, Ste R
Release ID: 89039903